MesoTV Podcast: Conversations Impacting the Mesothelioma Community
En podkast av Mesothelioma Applied Research Foundation
39 Episoder
-
MesoTV: The surgical approach to meso and how genetics impact treatment
Publisert: 14.12.2021 -
Radiation and immunotherapy: emerging mechanisms of synergy w/ Dr. Breen from Mayo Clinic
Publisert: 9.11.2021 -
Chemotherapy + immunotherapy, another positive step in mesothelioma treatment
Publisert: 9.11.2021 -
”Does staging matter in mesothelioma” with Dr. James Stevenson of the Cleveland Clinic
Publisert: 1.10.2021 -
Pneumonitis in immunotherapy-treated mesothelioma patients
Publisert: 30.9.2021 -
Peritoneal mesothelioma surgery and treatment at the National Cancer Institute
Publisert: 30.9.2021 -
Toxicities, side-effects, from immunotherapy for treatment of mesothelioma
Publisert: 13.7.2021 -
CLINICAL TRIAL: Engineered T-cell therapy (TC-210, gavo-cel) for mesothelioma
Publisert: 11.6.2021 -
CLINICAL TRIAL: Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Publisert: 25.5.2021 -
Current trends in mesothelioma treatment - discussion by thought-leaders in this disease
Publisert: 20.5.2021 -
Pain management for mesothelioma patients from a multi-disciplinary perspective
Publisert: 18.5.2021 -
Discussion of mesothelioma patients who underwent an EPP (extrapleural pneumonectomy - lung removal)
Publisert: 3.2.2021 -
Clinical trial assessing the addition of IMRT to pemetrexed (Alimta)/platinum based therapy
Publisert: 26.1.2021 -
Vaccination Considerations for Mesothelioma Patients
Publisert: 13.1.2021 -
Dr. Paul Sugarbaker discusses HIPEC in peritoneal mesothelioma
Publisert: 11.1.2021 -
Mesothelioma Patients Discuss "Chemo Brain"
Publisert: 7.1.2021 -
Inherited Genetics and Mesothelioma
Publisert: 6.1.2021 -
Life After Mesothelioma Treatment Community Panel
Publisert: 6.1.2021 -
FDA's Expanded Access and Compassionate Use Rules' Impact on Mesothelioma Treatment
Publisert: 6.1.2021
The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life. The Mesothelioma Applied Research Foundation is the only nonprofit charity organization dedicated to ending mesothelioma, and the suffering caused by this cancer, by: funding research to improve treatment options; providing treatment support and education for patients and their families; and advocating for federal funding of research.
